symmetric dimethylarginine has been researched along with Disease Exacerbation in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Doğan, Ö; Haşimi, A; Serdar, CC; Serdar, MA | 1 |
| Bahls, M; Böger, RH; Büttner, P; Hindricks, G; Kornej, J; Schwedhelm, E; Thiele, H | 1 |
| Bernasconi, L; Christ-Crain, M; Henzen, C; Hoess, C; Huber, A; Meier, MA; Mueller, B; Ottiger, M; Schuetz, P; Steuer, C; Thomann, R; Vögeli, A; Zimmerli, W | 1 |
| Bode-Böger, SM; Emrich, IE; Fliser, D; Heine, GH; Martens-Lobenhoffer, J; Wagenpfeil, S; Zawada, AM | 1 |
| Brooks, ER; Furth, SL; Haymond, S; Helenowski, I; Langman, CB; Passman, R; Pierce, C; Rademaker, A; Vicente, F; Warady, BA | 1 |
| Aldámiz-Echevarria, L; Andrade, F; Couce, ML; de Las Heras, J; Llarena, M | 1 |
| Delfraino, B; Hazen, SL; Hu, B; Klein, AL; Levison, BS; Shrestha, K; Tang, WH; Tong, W; Troughton, RW; Wang, Z | 1 |
| Amin, R; Dalton, RN; Dunger, DB; Marcovecchio, ML; Prevost, AT; Turner, C; Widmer, B | 1 |
| Michaluk-Skutnik, J; Taranta-Janusz, K; Wasilewska, A; Zoch-Zwierz, W | 1 |
| Djindjić, N; Ilić, M; Krstić, N; Mladenović, D; Nicković, J; Nicković, V; Nikolić, J | 1 |
| Bartáková, V; Bělobrádková, J; Jurajda, M; Kaňková, K; Klepárník, M; Krusová, D; Kuricová, K; Malúšková, D; Mužík, J; Olšovský, J; Pácal, L; Pavlík, T; Rehořová, J; Stěpánková, S; Svojanovský, J; Tanhäuserová, V; Tomandl, J | 1 |
11 other study(ies) available for symmetric dimethylarginine and Disease Exacerbation
| Article | Year |
|---|---|
Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients.
Topics: Arginine; COVID-19; Disease Progression; Humans; omega-N-Methylarginine | 2023 |
Arginine derivatives in atrial fibrillation progression phenotypes.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Cohort Studies; Disease Progression; Female; Homoarginine; Humans; Male; Middle Aged; Phenotype | 2020 |
Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Disease Progression; Female; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Risk Factors; Severity of Illness Index; Survival Rate; Switzerland; Time Factors | 2017 |
Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, Liquid; Disease Progression; Female; Germany; Humans; Incidence; Male; Middle Aged; omega-N-Methylarginine; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors | 2018 |
Contribution of symmetric dimethylarginine to GFR decline in pediatric chronic kidney disease.
Topics: Adolescent; Arginine; Child; Child, Preschool; Chromatography, High Pressure Liquid; Disease Progression; Female; Glomerular Filtration Rate; Humans; Infant; Kidney; Male; Mass Spectrometry; Prospective Studies; Renal Insufficiency, Chronic | 2018 |
Dimethylarginines as biomarkers for the kidney transplant management in methylmalonic aciduria.
Topics: Adult; Allografts; Amino Acid Metabolism, Inborn Errors; Arginine; Biomarkers; Cause of Death; Disease Progression; Fatal Outcome; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Pancreatitis; Predictive Value of Tests; Risk Factors; Time Factors; Treatment Outcome | 2015 |
Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure.
Topics: Arginine; Biomarkers; Chronic Disease; Diastole; Disease Progression; Echocardiography, Doppler; Electrocardiography; Female; Heart Failure, Systolic; Humans; Male; Methylation; Middle Aged; Natriuretic Peptides; Nitric Oxide; Predictive Value of Tests; Prospective Studies; Renal Insufficiency; Tandem Mass Spectrometry; Treatment Outcome; Ventricular Remodeling | 2008 |
Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes.
Topics: Adolescent; Age of Onset; Albuminuria; Arginine; Biomarkers; Child; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; England; Epidemiologic Methods; Female; Glomerular Filtration Rate; Humans; Male; Prognosis | 2010 |
Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents?
Topics: Adolescent; Arginine; Biomarkers; Case-Control Studies; Child; Child, Preschool; Chronic Disease; Cross-Sectional Studies; Cystatin C; Disease Progression; Female; Glomerular Filtration Rate; Humans; Infant; Kidney; Kidney Diseases; Male; ROC Curve; Sensitivity and Specificity; Young Adult | 2012 |
Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis.
Topics: Adult; Aged; Arginine; Biomarkers; Creatinine; Disease Progression; Hepatorenal Syndrome; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged | 2012 |
ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
Topics: Adult; Aged; Amidohydrolases; Arginine; Cross-Sectional Studies; Czech Republic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Humans; Male; Methylation; Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Reproducibility of Results; Risk Factors | 2012 |